Predicting CHD risk in patients with diabetes mellitus

This publication has 11 references indexed in Scilit:

• Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men
  Heart, 1999
• Cardiovascular Events and Their Reduction With Pravastatin in Diabetic and Glucose-Intolerant Myocardial Infarction Survivors With Average Cholesterol Levels
  Circulation, 1998
• Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction
  New England Journal of Medicine, 1998
• Cholesterol Lowering With Simvastatin Improves Prognosis of Diabetic Patients With Coronary Heart Disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)
  Diabetes Care, 1997
• Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
  New England Journal of Medicine, 1995
• Cardiovascular disease risk profiles
  American Heart Journal, 1991
• An updated coronary risk profile. A statement for health professionals.
  Circulation, 1991
• The Impact of Diabetes on Survival Following Myocardial Infarction in Men vs Women
  JAMA, 1988
• Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham Study
  Diabetes Care, 1979
• Diabetes and cardiovascular risk factors: the Framingham study.
  Circulation, 1979